Holen Sie sich die Stockscreener-App
225.30
2.73%
5.98
Handel nachbörslich:
225.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$219.32
Offen:
$217.8
24-Stunden-Volumen:
1.02M
Relative Volume:
1.38
Marktkapitalisierung:
$12.70B
Einnahmen:
$16.08B
Nettoeinkommen (Verlust:
$1.20B
KGV:
12.64
EPS:
17.82
Netto-Cashflow:
$1.06B
1W Leistung:
+7.08%
1M Leistung:
+12.05%
6M Leistung:
+31.08%
1J Leistung:
+9.41%
1-Tages-Spanne:
$217.70
$227.22
1-Wochen-Bereich:
$200.70
$227.22
52-Wochen-Spanne:
$152.33
$227.22
Universal Health Services Inc Stock (UHS) Company Profile
Firmenname
Universal Health Services Inc
Sektor
Branche
Telefon
(610) 768-3300
Adresse
367 S GULPH RD, KING OF PRUSSIA, PA
Vergleichen Sie UHS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UHS
Universal Health Services Inc
|
225.30 | 13.96B | 16.08B | 1.20B | 1.06B | 17.82 |
|
HCA
Hca Healthcare Inc
|
468.40 | 109.15B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
209.14 | 18.08B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.90 | 15.90B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
125.63 | 12.72B | 5.51B | 494.70M | 386.40M | 4.84 |
Universal Health Services Inc Stock (UHS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Fortgesetzt | Goldman | Neutral |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-02-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-06 | Fortgesetzt | BofA Securities | Neutral |
| 2024-10-16 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-07-26 | Hochstufung | Cantor Fitzgerald | Underweight → Neutral |
| 2024-06-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-11 | Hochstufung | Goldman | Sell → Buy |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-30 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-04-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Underweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Neutral |
| 2023-03-01 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-01-24 | Hochstufung | UBS | Sell → Neutral |
| 2023-01-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-16 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-03-29 | Eingeleitet | Wells Fargo | Underweight |
| 2022-02-28 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-09-08 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Underweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-01-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-23 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-26 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-18 | Herabstufung | Goldman | Buy → Neutral |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-10-11 | Eingeleitet | Stephens | Equal-Weight |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-27 | Hochstufung | Mizuho | Neutral → Buy |
Alle ansehen
Universal Health Services Inc Aktie (UHS) Neueste Nachrichten
Universal Health Services' Behavioral Health Volumes Remain Key Debate, Morgan Stanley Says - MarketScreener
UHS raises revenue guidance for 2025 - Healthcare Dive
Cantor Fitzgerald Maintains Neutral Rating on UHS, Raises Price Target | UHS Stock News - GuruFocus
UHS Analyst Rating Update: Guggenheim Raises Price Target to $25 - GuruFocus
Universal Health Services, Inc. (NYSE:UHS) Q3 2025 Earnings Call Transcript - Insider Monkey
Stephens Adjusts Price Target on Universal Health Services to $235 From $215, Maintains Equalweight Rating - MarketScreener
Guggenheim Adjusts Price Target on Universal Health Services to $253 From $227, Maintains Buy Rating - MarketScreener
Health systems governance: Advancing universal health coverage in India through recognition of allied and healthcare professionals - Express Healthcare
Behavioral Rehabilitation Market Booming Rapidly Through 2032 - openPR.com
Universal Health Services Reports Strong Q3 2025 Results - TipRanks
Using economic indicators to assess Universal Health Services Inc. potentialQuarterly Portfolio Report & Long-Term Investment Growth Plans - newser.com
Universal Health Services (UHS) Profit Margin Gains Challenge Cautious Growth Narratives - Yahoo Finance
UHS Earnings Call: Mixed Outlook with Strong EPS Growth - TipRanks
Legacy Behavioral Health Provider UHS Doubles Down on Outpatient Strategy - Behavioral Health Business
Universal Health's Q3 Earnings Top on Patient Volumes, Ups '25 EPS View - sharewise.com
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday? - Benzinga
UHS Q3 Deep Dive: Acute Care Growth and Outpatient Expansion Shape Outlook - Yahoo! Finance Australia
Earnings call transcript: Universal Health Services Q3 2025 beats expectations - Investing.com
Barclays Raises Price Target for UHS to $263, Maintains Overweig - GuruFocus
Why Universal Health Services (UHS) is a Top Growth Stock for the Long-Term - Yahoo Finance
Universal Health Services, Inc. (UHS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Universal Health Services Inc (UHS) Q3 2025 Earnings: EPS of $5. - GuruFocus
Universal Health Services, Inc. Announces Financial Results - TradingView
Best Growth Stocks to Buy for Oct. 28th - Zacks Investment Research
Why Universal Health Shares Are Under Pressure - TipRanks
Barclays Adjusts Price Target on Universal Health Services to $263 From $250, Keeps Overweight Rating - MarketScreener
Leerink Partners Adjusts PT on Universal Health Services to $284 From $276, Keeps Outperform Rating - MarketScreener
Universal Health Services Trades At A Discount Despite Solid Results - Finimize
Universal Health Services stock holds Outperform rating at Mizuho By Investing.com - Investing.com Canada
Will Universal Health Services Inc. outperform the marketJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
Can Universal Health Services Inc. stock rebound after recent weaknessTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
Is Universal Health Services Inc. (UHS) stock good for wealth creation2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Using data filters to optimize entry into Universal Health Services Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Universal Health Services: Q3 Earnings Snapshot - CT Insider
Will Universal Health Services Inc. (UHS) stock boost dividends further2025 Short Interest & Daily Profit Maximizing Tips - Fundação Cultural do Pará
Sentiment Recap: How Universal Health Services Inc. stock performs during Fed tightening cyclesJuly 2025 Analyst Calls & Free High Return Stock Watch Alerts - Fundação Cultural do Pará
Universal Health Services (UHS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
Universal Health Services Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Universal Health Services Outpaces Profit Estimates On Hospital Demand - Finimize
Universal Health Services beats quarterly profit estimates on higher medical care demand - Reuters
Universal Health Services Q3 2025 Earnings ReportRevenue Growth & Raised GuidanceNews and Statistics - IndexBox
Universal Health Services (UHS) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Universal Health Services (NYSE:UHS) Surprises With Q3 Sales, Stock Soars - Yahoo Finance
Universal Health Services Posts Strong Growth And Ups Guidance - Finimize
Universal Health Services, Inc. Reports Advance In Q3 Bottom Line - Nasdaq
Universal Health Services shares jump 5% on better-than-expected FY25 guidance - Investing.com UK
Universal Health Realty Income Trust Reports Financial Results - TradingView
(UHS) Universal Health Services Expects Full-Year 2025 Revenue Range $17.31 Billion$17.45 Billion, vs. FactSet Est of $17.20 Billion - MarketScreener
Universal Health's Q3 profit beats estimates boosted by Medicaid reimbursements - MarketScreener
(UHS) Universal Health Services Expects 2025 Adjusted EPS Range $21.50$22.10, vs. FactSet Est of $20.65 - MarketScreener
Universal Health Services earnings beat by $0.85, revenue topped estimates - Investing.com UK
Finanzdaten der Universal Health Services Inc-Aktie (UHS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
2.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):